Related Experiment Video
Updated: Aug 13, 2026
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
DNA drug design for cancer therapy
1BRL, CCR, National Cancer Institute, Bethesda, MD 20892-1750, USA. yc12b@nih.gov
Current Pharmaceutical Design
|August 17, 2005
Summary
DNA drugs offer a direct genetic approach to cancer treatment by blocking cancer-promoting genes. Advances in antisense technology are leading to more effective and less toxic nucleic acid medicines for future cancer therapy.
Area of Science:
- Molecular Biology
- Genetics
- Pharmacology
Background:
- Antisense oligonucleotides represent a direct genetic strategy for cancer treatment.
- This approach targets genes that provide a growth advantage to neoplastic cells.
- Blocking these genes allows for the study of normal growth regulation.
Purpose of the Study:
- To review the progress and potential of DNA drug technology in cancer treatment.
- To highlight the shift towards a genomic-scale understanding of antisense inhibition.
- To emphasize the development of more effective and less toxic nucleic acid medicines.
Main Methods:
- Review of current DNA drug technology and antisense inhibition strategies.
- Examination of the genomic-scale application of antisense technology.
- Analysis of clinical trial data for antisense oligonucleotides.
Main Results:
- Antisense technology has advanced rapidly, moving towards a genomic scale.
- This global view aims to reduce nonspecific and undesirable side effects.
- Several antisense oligonucleotides are in clinical trials, showing good tolerability and potential therapeutic activity.
Conclusions:
- DNA drugs are promising molecular medicines for future human cancer treatment.
- The evolution of antisense technology is paving the way for safer and more effective nucleic acid medicines.
- Continued research and clinical trials are essential to realize the full potential of DNA-based cancer therapies.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
Related Concept Videos
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...